Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study

Authors:

Abstract
Background: According to the literature, about one third of patients with brain ischemic symptoms lasting 2 score. To assess the impact of acute brain ischemic lesions on 90-day prognosis, we performed a propensity score matching of patients with and without those lesions. We adopted a primary effectiveness outcome which was a composite of new stroke/TIA events and death due to vascular causes at 90 days. Results: We included 517 patients—324 (62.7%) male—with a median (interquartile range—IQR) age of 74 (IQR = 65–81) years; 144 patients (27.9%) had acute brain ischemic lesions at neuroimaging. The proportion of patients with brain ischemic lesions did not vary according to the ABCD 2 score. At follow-up, 4 patients with brain ischemic lesions (2.8%) and 21 patients without lesions (5.6%) reported the primary effectiveness outcome, which was similar between the groups before ( p = 0.178) and after matching ( p = 0.518). Conclusions: In our population, patients with transient ischemic symptoms and acute ischemic lesions at brain magnetic resonance imaging (MRI) had a risk of recurrent ischemic events similar to those without lesions. The risk of recurrent ischemic events was low in both groups.

This publication has 22 references indexed in Scilit: